表紙
市場調查報告書

末稍血管栓塞保護裝置:醫療設備的開發平台評估

Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 338378
出版日期 內容資訊 英文 104 Pages
訂單完成後即時交付
價格
末稍血管栓塞保護裝置:醫療設備的開發平台評估 Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月18日內容資訊: 英文 104 Pages
簡介

本報告提供全球各國的企業·醫療機關等開發中的,末稍血管栓塞保護裝置之開發中產品資訊相關分析,提供臨床實驗/產品開發的整體進展,及各階段·各領域·各地區的詳細趨勢,各企業·各產品的詳細資訊 (臨床實驗的進展階段,開始/結束時期,認證預測等),近來的產品開發的動向·產業趨勢等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 末稍血管栓塞保護裝置概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各部門
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各認證時期 (估計)
  • 現在進行中的臨床實驗

第4章 末稍血管栓塞保護裝置:正在開發的開發中產品 (各企業)

  • 末稍血管栓塞保護裝置的開發企業:開發中產品 (各開發階段)
  • 末稍血管栓塞保護裝置:各開發階段的開發中產品一覽

第5章 末稍血管栓塞保護裝置的開發企業·產品概要

  • Abbott Vascular Inc.
    • 開發中產品及進行中的臨床實驗概要
  • Avantec Vascular Corporation 5.3 BTG Plc
  • Cardio-Flow Ltd.
  • CardioGard Ltd.
  • EMBA Medical Limited
  • Emboline, Inc.
  • Filterlex Medical Ltd
  • Inari Medical, Inc.
  • Innovative Cardiovascular Solutions, LLC
  • Innovia LLC
  • Keystone Heart Ltd
  • Medtronic plc
  • Metactive Medical LLC
  • MIV Therapeutics Inc
  • Neurosonix Ltd.
  • Shape Memory Therapeutics, Inc. Company
  • Trinity College Dublin
  • University of Minnesota

第6章 末稍血管栓塞保護裝置:近來的市場趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0872EPD

GlobalData's Medical Devices sector report, "Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Peripheral Embolic Protection Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Embolic Protection Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Peripheral Embolic Protection Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Peripheral Embolic Protection Devices Overview 7

3 Products under Development 8

  • 3.1 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 8
  • 3.2 Peripheral Embolic Protection Devices - Pipeline Products by Segment 9
  • 3.3 Peripheral Embolic Protection Devices - Pipeline Products by Territory 10
  • 3.4 Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path 11
  • 3.5 Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date 12
  • 3.6 Peripheral Embolic Protection Devices - Ongoing Clinical Trials 13

4 Peripheral Embolic Protection Devices - Pipeline Products under Development by Companies 14

  • 4.1 Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development 14
  • 4.2 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 15

5 Peripheral Embolic Protection Devices Companies and Product Overview 16

  • 5.1 Abbott Vascular Inc Company Overview 16
    • 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.2 Artio Medical Company Overview 17
    • 5.2.1 Artio Medical Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.3 Avantec Vascular Corp Company Overview 18
    • 5.3.1 Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.4 BTG Plc Company Overview 19
    • 5.4.1 BTG Plc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.5 Capture Vascular Inc Company Overview 20
    • 5.5.1 Capture Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.6 Cardio-Flow Ltd. Company Overview 22
    • 5.6.1 Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.7 Cardiovascular Systems Inc Company Overview 23
    • 5.7.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.8 Emboline, Inc. Company Overview 25
    • 5.8.1 Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.9 Filterlex Medical Ltd Company Overview 28
    • 5.9.1 Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.10 Innovative Cardiovascular Solutions, LLC Company Overview 29
    • 5.10.1 Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.11 Innovia LLC Company Overview 32
    • 5.11.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.12 Javelin Medical Ltd Company Overview 33
    • 5.12.1 Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.13 Keystone Heart Ltd Company Overview 36
    • 5.13.1 Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.14 Medtronic plc Company Overview 38
    • 5.14.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.15 MIV Therapeutics Inc Company Overview 39
    • 5.15.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.16 Neurosonix Ltd. Company Overview 40
    • 5.16.1 Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.17 Protembis GmbH Company Overview 41
    • 5.17.1 Protembis GmbH Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.18 University of Minnesota Company Overview 42
    • 5.18.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.19 University of Toledo Company Overview 43
    • 5.19.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 43

6 Peripheral Embolic Protection Devices- Recent Developments 44

  • 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 44
  • 6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 46
  • 6.3 Nov 07, 2019: Penumbra reports third quarter 2019 financial results 47
  • 6.4 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 48
  • 6.5 Oct 23, 2019: Edwards Lifesciences reports third quarter results 50

7 Appendix 101

  • 7.1 Methodology 101
  • 7.2 About GlobalData 104
  • 7.3 Contact Us 104
  • 7.4 Disclaimer 104

List of Tables

  • Table 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
  • Table 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment
  • Table 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory
  • Table 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
  • Table 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
  • Table 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials
  • Table 7: Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development
  • Table 8: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
  • Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status
  • Table 11: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description
  • Table 12: Artio Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Blockstent Microcatheter - Product Status
  • Table 14: Blockstent Microcatheter - Product Description
  • Table 15: Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Peripheral Embolization Device - Product Status
  • Table 17: Peripheral Embolization Device - Product Description
  • Table 18: BTG Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: EKOS Control Unit - New - Product Status
  • Table 20: EKOS Control Unit - New - Product Description
  • Table 21: Capture Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Megavac - BTK - Product Status
  • Table 23: Megavac - BTK - Product Description
  • Table 24: Thrombowire Clot Retractor - BTK - Product Status
  • Table 25: Thrombowire Clot Retractor - BTK - Product Description
  • Table 26: Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: EmboPRO EPD - Product Status
  • Table 28: EmboPRO EPD - Product Description
  • Table 29: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: WIRION EPD System - LE Atherectomy - Product Status
  • Table 31: WIRION EPD System - LE Atherectomy - Product Description
  • Table 32: Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Emboliner - Product Status
  • Table 34: Emboliner - Product Description
  • Table 35: Emboline, Inc. - Ongoing Clinical Trials Overview
  • Table 36: Emboliner - A Prospective, Non-randomized, Multi-center, Open-label Clinical Investigation to Assess the Safety and Technical Performance of the Emboliner Embolic Protection Catheter
  • Table 37: Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: CAPTIS - Product Status
  • Table 39: CAPTIS - Product Description
  • Table 40: Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: EMBLOK Embolic Protection System - Product Status
  • Table 42: EMBLOK Embolic Protection System - Product Description
  • Table 43: Innovative Cardiovascular Solutions, LLC - Ongoing Clinical Trials Overview
  • Table 44: EMBLOK Embolic Protection System - European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR)
  • Table 45: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Permanently Implantable Embolic Balloon - Product Status
  • Table 47: Permanently Implantable Embolic Balloon - Product Description
  • Table 48: Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Vine - Product Status
  • Table 50: Vine - Product Description
  • Table 51: Javelin Medical Ltd - Ongoing Clinical Trials Overview
  • Table 52: Vine - Carotid Artery Implant for Trapping Upstream Emboli (CAPTURE 2) for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants
  • Table 53: Vine - Carotid Artery Implant for Trapping Upstream Emboli for Preventing Stroke in Atrial Fibrillation Patients
  • Table 54: Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: TriGuard 3 - Product Status
  • Table 56: TriGuard 3 - Product Description
  • Table 57: TriGuard Cerebral Protection Device - Product Status
  • Table 58: TriGuard Cerebral Protection Device - Product Description
  • Table 59: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
  • Figure 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment
  • Figure 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory
  • Figure 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
  • Figure 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
  • Figure 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials